NCT00576667 An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes Status TERMINATED Phase PHASE3
NCT00576368 An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice Status COMPLETED Phase PHASE4
NCT00575913 Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study Status COMPLETED Phase PHASE4
NCT00574275 Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE3
NCT00566657 Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions Status COMPLETED Phase PHASE3
NCT00565448 Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents Status COMPLETED Phase PHASE2
NCT00565162 Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus Status COMPLETED Phase PHASE4
NCT00564187 Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice Status COMPLETED Phase PHASE4
NCT00563914 A Comparative Safety and Activity Study With Ferroquine Associated With Artesunate Versus Amodiaquine Associated With Artesunate in African Adult Patients With Uncomplicated Malaria Status COMPLETED Phase PHASE1/PHASE2
NCT00563771 Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome Status COMPLETED Phase PHASE4
NCT00562809 The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension Status COMPLETED Phase PHASE4
NCT00562172 Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study) Status COMPLETED Phase PHASE4
NCT00561964 Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria Status COMPLETED Phase PHASE3
NCT00561470 Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen Status COMPLETED Phase PHASE3
NCT00559455 Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00559429 Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer Status COMPLETED Phase PHASE1